Control group:radiotherapy and chemotherapy
Sponsors
The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Shanghai Pulmonary Hospital, Affiliated hospital of Zunyi Medical University
Conditions
Inoperable stage III non-small cell lung cancerNon-small cell lung cancerRadiation oral/ oropharyngeal mucositis in concurrent chemoradiotherapy for nasopharyngeal carcinomaradiation oral/ oropharyngeal mucositis in concurrent chemoradiotherapy for nasopharyngeal carcinoma
Early Phase 1
Study for the effect of traditional Chinese medicine on the enhancement and attenuation of local advanced non-small cell lung cancer during radiotherapy and chemotherapy
Active, not recruitingITMCTR2000003189
Start: 2020-05-01Updated: 2023-02-20
Study for the effect of traditional Chinese medicine on the enhancement and attenuation of local advanced non-small cell lung cancer during radiotherapy and chemotherapy
Active, not recruitingChiCTR2000031667
Start: 2020-05-01Updated: 2020-04-13
Unknown Phase
Human recombinant endostatin (Endostar) combined with concurrent radiochemotherapy in patients with Inoperable stage III non-small cell lung cancer : a prospective, randomized controlled clinical study
Active, not recruitingChiCTR-IPR-17013479
Start: 2017-12-01Updated: 2018-02-05
Randomized, double-blind, controlled clinical trial of Xianshen Decotion formula granule in preventing and treating radiation-induced oral mucositis in patients with nasopharyngeal carcinoma
RecruitingChiCTR1900026352
Start: 2021-11-01Updated: 2022-01-18
A multi-center, randomized controlled clinical study for Xiansen Decoction combined with radiotherapy and chemotherapy in the treatment of locally advanced nasopharyngeal carcinoma
RecruitingITMCTR1900002641
Start: 2019-10-02Updated: 2023-02-20